JOHNSON & JOHNSON Long-Term Concentrated

Location: NEW BRUNSWICK, NJ

CIK: 0000200406 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Jul 22, 2025

Total Value ($000): $334,096 (100.0% shares, 0.0% debt)

Holdings (20)

PTGX Protagonist Therapeutics Inc. 40.8%

Value ($000) $136,395 Shares 2,449,183 Est. Cost $42.63 Unrealized +12.6%

MGTX MeiraGTx Holdings plc 13.1%

Value ($000) $43,897 Shares 6,641,064 Est. Cost $9.84 Unrealized -40.0%

RAPP Rapport Therapeutics, Inc. 8.5%

Value ($000) $28,553 Shares 2,498,051 Est. Cost $23.15 Unrealized -54.2%

LEGN Legend Biotech Corporation 8.4%

Value ($000) $28,209 Shares 814,586 Est. Cost $50.56 Unrealized —

NBTX Nanobiotix S.A. 7.6%

Value ($000) $25,455 Shares 5,623,816 Est. Cost $7.53 Unrealized —

CVRX CVRx, Inc. 7.1%

Value ($000) $23,882 Shares 4,103,430 Est. Cost $19.85 Unrealized -65.2%

PRCT Procept BioRobotics Corporation 6.1%

Value ($000) $20,370 Shares 357,939 Est. Cost $38.38 Unrealized +47.3%

CTNM Contineum Therapeutics Inc. 2.4%

Value ($000) $8,134 Shares 1,979,173 Est. Cost $16.10 Unrealized -73.0%

XNCR Xencor, Inc. 1.8%

Value ($000) $6,089 Shares 748,062 Est. Cost $37.91 Unrealized -76.3%

ARWR Arrowhead Pharmaceuticals, Inc. 1.2%

Value ($000) $3,981 Shares 247,598 Est. Cost $64.75 Unrealized -77.8%

FATE Fate Therapeutics, Inc. 1.1%

Value ($000) $3,514 Shares 3,379,064 Est. Cost $78.44 Unrealized -98.5%

NMRA Neumora Therapeutics, Inc. 0.4%

Value ($000) $1,400 Shares 1,849,445 Est. Cost $12.57 Unrealized -94.0%

— Rallybio Corporation 0.4%

Value ($000) $1,209 Shares 3,636,363 Est. Cost $1.34 Unrealized —

— Vor Biopharma, Inc. 0.3%

Value ($000) $1,139 Shares 1,074,658 Est. Cost $15.68 Unrealized —

NNOX Nano-X Imaging Ltd. 0.2%

Value ($000) $831 Shares 158,852 Est. Cost $15.61 Unrealized -67.3%

LAB Standard BioTools Inc 0.1%

Value ($000) $371 Shares 311,967 Est. Cost $2.41 Unrealized -54.1%

— Lyell Immunopharma Inc. 0.1%

Value ($000) $368 Shares 41,165 Est. Cost $0.64 Unrealized —

— Adicet Bio, Inc. 0.1%

Value ($000) $228 Shares 364,472 Est. Cost $7.84 Unrealized —

— BiomX Inc. 0.0%

Value ($000) $43 Shares 96,866 Est. Cost $3.06 Unrealized —

— Senseonics Holdings, Inc. 0.0%

Value ($000) $27 Shares 54,621 Est. Cost $3.39 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PTGX	Protagonist Therapeutics Inc.	2,449,183	$136,395	40.8%	$42.63	+12.6%	COM	74366E102
MGTX	MeiraGTx Holdings plc	6,641,064	$43,897	13.1%	$9.84	-40.0%	COM	G59665102
RAPP	Rapport Therapeutics, Inc.	2,498,051	$28,553	8.5%	$23.15	-54.2%	COM	75383L102
LEGN	Legend Biotech Corporation	814,586	$28,209	8.4%	$50.56	—	SPONSORED ADS	52490G102
NBTX	Nanobiotix S.A.	5,623,816	$25,455	7.6%	$7.53	—	SPONSORED ADS	63009J107
CVRX	CVRx, Inc.	4,103,430	$23,882	7.1%	$19.85	-65.2%	COM	126638105
PRCT	Procept BioRobotics Corporation	357,939	$20,370	6.1%	$38.38	+47.3%	COM	74276L105
CTNM	Contineum Therapeutics Inc.	1,979,173	$8,134	2.4%	$16.10	-73.0%	CL A	21217B100
XNCR	Xencor, Inc.	748,062	$6,089	1.8%	$37.91	-76.3%	COM	98401F105
ARWR	Arrowhead Pharmaceuticals, Inc.	247,598	$3,981	1.2%	$64.75	-77.8%	COM	04280A100
FATE	Fate Therapeutics, Inc.	3,379,064	$3,514	1.1%	$78.44	-98.5%	COM	31189P102
NMRA	Neumora Therapeutics, Inc.	1,849,445	$1,400	0.4%	$12.57	-94.0%	COM	640979100
—	Rallybio Corporation	3,636,363	$1,209	0.4%	$1.34	—	COM	75120L100
—	Vor Biopharma, Inc.	1,074,658	$1,139	0.3%	$15.68	—	COM	929033108
NNOX	Nano-X Imaging Ltd.	158,852	$831	0.2%	$15.61	-67.3%	ORD SHS	M70700105
LAB	Standard BioTools Inc	311,967	$371	0.1%	$2.41	-54.1%	COM	34385P108
—	Lyell Immunopharma Inc.	41,165	$368	0.1%	$0.64	—	COM	55083R104
—	Adicet Bio, Inc.	364,472	$228	0.1%	$7.84	—	COM	007002108
—	BiomX Inc.	96,866	$43	0.0%	$3.06	—	COM	09090D103
—	Senseonics Holdings, Inc.	54,621	$27	0.0%	$3.39	—	COM	81727U105